FIELD: medicine.
SUBSTANCE: invention relates to a Leuconostoc citreum WiKim0104 strain and use thereof. Presented is a Leuconostoc citreum WiKim0104 strain with identification number KCCM12420P intended for preventing, relieving or treating a disease associated with accumulation of fat in hepatocytes selected from inflammation, obesity or fatty liver disease. Also disclosed is the use of said strain or its culture to prevent, relieve or treat a disease associated with accumulation of fat in hepatocytes, selected from inflammation, obesity or fatty liver disease. Also disclosed is a composition containing said strain or culture thereof, and a method for preventing, relieving or treating a disease, associated with accumulation of fat in hepatocytes, selected from inflammation, obesity or fatty liver disease, involving administering said composition to a subject in need thereof.
EFFECT: invention provides inhibitory action on development of fatty liver disease by inhibiting fat accumulation in liver cells and reducing expression of genes associated with fatty liver disease.
12 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION AND METHOD OF PREVENTION, REMOVAL OF SYMPTOMS OR THERAPEUTIC EFFECT ON LIVER DAMAGE | 2020 |
|
RU2810601C2 |
BIFIDOBACTERIUM LONGUM FOR TREATING OBESITY AND RELATED METABOLIC DISORDERS | 2016 |
|
RU2740096C2 |
USING LACTITOL AND AN ORAL DOSAGE FORM FOR TREATING AND PREVENTING NON-ALCOHOLIC FATTY LIVER DISEASE | 2018 |
|
RU2692243C1 |
ANTYSTEATOSIS AGENT | 2019 |
|
RU2702003C1 |
PHARMACEUTICAL COMPOSITION FOR NON-ALCOHOLIC FATTY LIVER DISEASE PREVENTION OR TREATMENT | 2013 |
|
RU2635966C2 |
THERAPEUTIC AGENT FOR LIVER DISEASES | 2018 |
|
RU2723686C1 |
SYMBIOTIC COMPOSITION FOR PREVENTION OF METABOLIC DISORDERS | 2018 |
|
RU2771744C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATHOEPATITIS | 2021 |
|
RU2803733C1 |
COMPOSITION FOR PREVENTING OR TREATING FATTY LIVER DISEASES | 2015 |
|
RU2664696C2 |
PREVENTIVE AND THERAPEUTIC DRUG FOR NON-ALCOHOLIC FATTY LIVER DISEASE | 2018 |
|
RU2820552C2 |
Authors
Dates
2024-04-04—Published
2020-02-27—Filed